CURRENTLY ACCEPTING APPLICATIONS FOR AY28 (07/2027 - 06/2028).
The application facilitated through this site is for clinical research training*. A detailed description of the clinical research training tracks is provided below. Please read the instructions and review your application carefully.
*NOTE: Applications for clinical training will be facilitated through SF Match. Please visit SF Match for additional information and to register. Once you are registered, you will be able to view programs accepting applications. We are unable to accept match applications directly. You may also visit the ACTRIMS site for additional information about the MS & Neuroimmunology match process.
- Clinical research fellowship applications are due by 11:59pm ET on Sunday, December 15, 2025. Late applications will not be accepted.
- A complete application consists of an application form, a personal statement, current CV, and at least two letters of recommendation (provided directly from the referee).
- Should you not receive a confirmation that your application is complete, please be sure to reach out prior to the deadline. We recommend adding msfellowship@bwh.harvard.edu to your contacts to avoid any messages going to spam.
- Please do not submit duplicate applications via SF Match, as only one application will be considered. If you accidentally submit in both places, please contact us immediately.
- Inquiries and application materials may be sent to msfellowship@bwh.harvard.edu.
Program Leadership:
- Dr. Eric Klawiter, Director
- Dr. Sarah Conway, Associate Director
The Mass General Brigham Multiple Sclerosis & Neuroimmunology (MGB-MSNI) Fellowship Program (formerly known as the Partners MS Fellowship Program) is one of the most sought-after training programs in its field and has trained over 30 fellows since 2011 to meet the growing needs of MS and neuroimmunology patients. The MSNI Program is a hybrid program comprised of clinical and clinical research tracks offered through the Brigham and Women’s Hospital (BWH) and Massachusetts General Hospital (MGH), academically affiliated with Harvard Medical School (HMS). The program has had an excellent track record of doing so, with 100% of recent graduates remaining as MS specialists. More than 80% hold academic positions in MS Centers and are currently training their fellows themselves. In addition, Fellows participate in ongoing clinical research studies, both within the clinical setting and in conjunction with our affiliated research center, the Ann Romney Center for Neurologic Diseases (ARCND). Fellows are also academically credentialed through Harvard Medical School (HMS). Training is comprised of directly supervised MS patient care, exposure to multidisciplinary care, and inpatient management. To complement the in-clinic training, we have developed a comprehensive educational curriculum led by our expert faculty consisting of MS clinical case conferences, MRI conferences, MS seminars and clinical and research seminars focused on neuroimmunology more broadly. There are elective opportunities in non-MS neuroimmunological diseases. The infrastructure of the Program is consistent for both the clinical and clinical research tracks. Fellows completing the MSNI Fellowship Program will develop a strong knowledge base in MS pathophysiology, epidemiology, diagnosis, and management as well as subspecialty topics including women’s health and progressive MS. In addition, the Fellow will develop expertise in the management of NMOSD, MOGAD, and autoimmune encephalitis. Accordingly, they will understand differential diagnostic considerations and how to apply them to a particular clinical situation. The overall goal is to achieve excellence and independence in the comprehensive care of people with MS.
Clinical Fellows:
- Rotate through the outpatient clinics at the Brigham MS Center at the Brigham and Women’s Hospital and the MGH MS and NMO Clinic for 1-2 years in preparation for a career as a MS specialist.
- Training is comprised of direct supervised MS patient care, exposure to multidisciplinary care, didactic activities and exposure and participation in clinical trials.
- The clinical fellowship involves 5 supervised clinics each week and exposure to ongoing research activities at the Brigham MS Center.
- Applications for this track are managed through a match, please visit https://sfmatch.org/ for more information.
Clinical Research Fellows:
- This track involves supervised clinics in MS, NMO, and Neuroimmunology (across multiple institutions) and a focused research trajectory.
- CLIMB: Conduct research in biomarker clinical correlates and predictors of MS disease course (www.climbstudy.org). PI: Tanuja Chitnis, MD (BWH)
- Neuroimmunology: NMO mouse models of toleration, MOG T-cell activation studies, TM-familial genetics, and clinical trials – acute and preventative. PI: Michael Levy, MD (MGH)
- MS Neuroimaging and Clinical Trials: Training in therapeutic clinical trial design and implementation and/or applying novel imaging techniques such as tissue microstructure (myelin, axonal markers on our high-gradient Connectome MRI), connectivity imaging (diffusion, resting state) to MS. PI: Eric Klawiter, MD (MGH)
The program is funded by the National MS Society, Novartis, and Tiziana Life Sciences; individual fellowship funding opportunities may be applied for. This program is internally reviewed by the Mass General Brigham (MGB) Education Committee and administered by MGB Graduate Medical Education (GME). Eligible applicants will have successfully completed a residency training program in the US or Canada. Please reference the institutional policy surrounding USMLE completion for clinical trainees.
